We analyzed data from three cohorts: the UK Biobank, the Avon Longitudinal Study of Parents and Children (ALSPAC) study, and the Generation R study. The UK Biobank is a longitudinal study of approximately 500,000 adults aged 40 to 70 years, who were recruited between January 2006 and October 2010.
25 Participants attended a baseline visit at one of 22 assessment centers across England, Scotland, and Wales. Genotyping of participants was reported by Bycroft et al.
26 Ethics approval for the study was obtained from the Northwest Multi-center Research Ethics Committee (Reference: 11/NW/0382). Participants provided informed consent and were free to withdraw from the study at any time. The research adhered to the tenets of the Declaration of Helsinki. The ALSPAC study
27,28 recruited pregnant women resident in Avon, England, with expected dates of delivery April 1991 to December 1992. After the age of 7 years, attempts were made to bolster the initial sample with eligible cases who had failed to join the study originally, which resulted in an additional 913 children being enrolled. The total sample size for children alive at 1 year of age was 14,901, along with their mothers or guardians. The study website contains details of all the data that are available through a fully searchable data dictionary and variable search tool:
http://www.bristol.ac.uk/alspac/researchers/our-data/. Genotyping of participants was reported by Warrington et al.
29 Ethics approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees (Refs: E1808/ E4168/ E5215/ E5691/ E5806/ 06/Q2006/53). Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time. Consent for biological samples was collected in accordance with the Human Tissue Act (2004). The Generation R study
30,31 is a population-based prospective cohort study from fetal life to adulthood. A total of 9778 pregnant women residing in Rotterdam, The Netherlands, with a delivery date from April 2002 until January 2006 were recruited. Genotyping and quality control performed in the Generation R study were reported by Medina-Gomez C et al.
32 Ethics approval was obtained from the Medical Ethical Committee of Erasmus Medical Center, University Medical Center Rotterdam (Ref: MEC 217.595/2002/20). All participants provided written informed consent for each phase of the study (fetal, preschool, childhood, and adolescence period). Children provided consent from the age of 12 years onward, in accordance with Dutch Law.
Figure 1 provides an overview of how each cohort contributed to the design of the study.